JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JB Accepts, published online ahead of print on 2 March 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JB.01740-06v1
189/10/3721    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parish, T.
Right arrow Articles by Duncan, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parish, T.
Right arrow Articles by Duncan, K.

 Previous Article  |  Next Article 

J. Bacteriol. doi:10.1128/JB.01740-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG, but not Escherichia coli fabG

Tanya Parish*, Gretta Roberts, Francoise Laval, Merrill Schaeffer, Mamadou Daffé, and Ken Duncan

Centre for Infectious Disease, Institute of Cell and Molecular Science, Barts and the London, London, E1 2AT, UK; Institut de Pharmacologie et Biologie Structurale (UMR5089), Department of Molecular Mechanisms of Mycobacterial Infections, Centre National de la Recherche Scientifique and Université Paul Sabatier (Toulouse III), 205 Route de Narbonne, F-31077 Toulouse Cedex, France; GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA 19426, USA; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK

* To whom correspondence should be addressed. Email: t.parish{at}qmul.ac.uk.


   Abstract

Mycolic acids are a key component of the mycobacterial cell wall, providing structure and forming a major permeability barrier. In Mycobacterium tuberculosis mycolic acids are synthesised by type I and type II fatty acid synthases. One of the enzymes of the type II system is encoded by fabG1. We demonstrate that this gene can only be deleted from the M. tuberculosis chromosome when a second functional copy is provided elsewhere, showing that under normal culture conditions, fabG1 is essential. FabG1 activity can be replaced by the corresponding enzyme from the closely related species Mycobacterium smegmatis, but not by the enzyme from Escherichia coli. M. tuberculosis carrying FabG from M. smegmatis showed no phenotypic changes and both the mycolic acids and cell wall permeability were unchanged. Thus M. tuberculosis and M. smegmatis enzymes are interchangeable and do not control the length and types of mycolic acids synthesised.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.